Azora Therapeutics, Inc. (DE) AZR
NASDAQ AZR
$4.09 +0.35 (+9.36%)
At close: Nov 13, 2026 · 4:00 PM EST

Azora Therapeutics, Inc. (DE) (AZR) Return on Assets [ROA] (2018 - 2026)

Updated

Azora Therapeutics, Inc. (DE) (AZR) posted Return on Assets [ROA] of -244.59% for Q3 2026, down 118.17 percentage points from -126.42% a year earlier but up 90.41 percentage points from the prior quarter.

Analysis

Azora Therapeutics, Inc. (DE) (AZR) Return on Assets [ROA] (2018 - 2026) Analysis & Trends

For FY2025, Azora Therapeutics, Inc. (DE)'s Return on Assets [ROA] came in at -130.57%, up 139.30 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of +34.84 percentage points (FY2020 to FY2025).
  • In prior years, Azora Therapeutics, Inc. (DE)'s Return on Assets [ROA] was -269.87% in FY2024 (-172.00 pp), -97.87% in FY2023 (+94.91 pp), -192.79% in FY2022 (+106.81 pp) and -299.59% in FY2021 (-134.19 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -335.00% in Q2 2026 to a high of -123.87% in Q1 2026 over five years.
  • On a year-over-year basis, Return on Assets [ROA] increased in four of the last eight quarters, with an average year-over-year change of -13.29 percentage points.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q1 2024, with a gain of 112.00 percentage points; the weakest was Q2 2026, with a drop of 172.07 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -335.00% (Q2 2026), -123.87% (Q1 2026) and -124.03% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 8.08%
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 7.32%
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 1.87%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 9.36%
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 9.80%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -7.67%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 2.00%
10 Azora Therapeutics, Inc. (DE) 58.43 Mn -2.79 Mn - -244.59%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -244.59%
Jun 30, 2026 -335.00%
Mar 31, 2026 -123.88%
Dec 31, 2025 -124.03%
Sep 30, 2025 -126.42%
Jun 30, 2025 -162.93%
Mar 31, 2025 -210.78%
Dec 31, 2024 -224.51%
Sep 30, 2024 -223.76%
Jun 30, 2024 -210.44%
Mar 31, 2024 -152.25%
Dec 31, 2023 -134.75%
Sep 30, 2023 -182.65%
Jun 30, 2023 -202.95%
Mar 31, 2023 -264.25%
Dec 31, 2022 -188.97%
Sep 30, 2022 -169.19%
Jun 30, 2022 -136.60%
Mar 31, 2022 -164.11%
Dec 31, 2021 -217.81%
API Access

Azora Therapeutics, Inc. (DE) Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=AZR&period=max&api_key=YOUR_API_KEY